Drug intelligence / Profile preview

ibuprofen + menthol

Development stage
Unknown
Lead developer
Basic Pharma Manufacturing
Modality
Small Molecules
Administration
Topical
01

Overview

This drug is a topical combination product containing ibuprofen and menthol, developed and manufactured by Basic Pharma Manufacturing. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that acts as a non-selective inhibitor of the enzymes cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), thereby reducing the synthesis of pro-inflammatory prostaglandins. Menthol is a cyclic terpene alcohol that serves as a counter-irritant; it stimulates cold-sensitive TRPM8 receptors in the skin to produce a cooling sensation, which helps to alleviate pain through a gate-control mechanism. The gel formulation is designed for topical application to provide localized relief from pain and inflammation associated with musculoskeletal conditions such as backache, rheumatic pain, muscular aches, sprains, and strains.

Brand names
Deep ReliefDeep Relief Anti-Inflammatory GelDeep Relief Dual Action Gel
Other names
ibuprofen/menthol gelibuprofen and menthol topical gel
02

Targets

TRPA1 (Transient receptor potential cation channel subfamily A member 1)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on ibuprofen + menthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + menthol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call